OCGN will continue flying
This is my second shot on OCGN and still a similar analysis.
OCGN is still a relatively small market cap that can grow very quickly. Covaxin, their covid vaccine candidate is still waiting for FDA approval. Occugen is partenering with an indian company -Bharat Biotech and have a deal with them to market Covaxin in the U.S. The vaccine is already commercialized in a couple of countries, eg. India, Mexico, the Phillippines.. OCGN will be in charge of commercializing the vaccine in the US if it's approved. The vaccine phase 3 tests showed very good results, it achieved an overall efficacy of 78% and a 100% efficacy against severe covid19. With the J&J vaccine being put on hold, Covaxin has a key role to play. Any rumours or confirmed news about the FDA approval, will send the stock above 30$.
OCGN is still a relatively small market cap that can grow very quickly. Covaxin, their covid vaccine candidate is still waiting for FDA approval. Occugen is partenering with an indian company -Bharat Biotech and have a deal with them to market Covaxin in the U.S. The vaccine is already commercialized in a couple of countries, eg. India, Mexico, the Phillippines.. OCGN will be in charge of commercializing the vaccine in the US if it's approved. The vaccine phase 3 tests showed very good results, it achieved an overall efficacy of 78% and a 100% efficacy against severe covid19. With the J&J vaccine being put on hold, Covaxin has a key role to play. Any rumours or confirmed news about the FDA approval, will send the stock above 30$. 
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.